Market announcement

AS PRFoods

LEI code

529900PFXFO2ZDCRNK93

Size of the entity

Medium group

Economic activities

Financial and Insurance Activities

Country of registered office

Estonia

General information

Categories

Management interim statement or quarterly financial report

Unique data record identifier

5540

Submission date and time

20.05.2016 09:00:00

Content of announcement in Estonian

Title

PRF: ASi PRFoods 2016. aasta 1. kvartali konsolideeritud auditeerimata vahearuanne

Message

Tallinn, Eesti, 2016-05-20 08:00 CEST (GLOBE NEWSWIRE) --


ÜLEVAADE MAJANDUSTEGEVUSEST

JUHTKONNA KOMMENTAAR

2016. aasta 1. kvartali majandustulemustega võib rahule jääda. Hoolimata
asjaolust, et kaotasime oma tooteportfellist mitu private label ja HoReCa
toodet, suutsime kvartalikäibe võrrelduna aastataguse sama perioodiga hoida pea
samal tasemel. Lõhe hinna järsk tõus ei ole veel kandunud üle lõpptoodetesse,
kuna hindade korrigeerimine jaeturul on inertsiga ja seetõttu peaks lõpphindade
korrektsioon toimuma teisel poolaastal. Ettevõtte maksude - ja
amortisatsioonieelne kasum ( EBITDA) paranes samal ajal pea poole võrra. Grupi
bilanss on tugev, mis aitab meil vastu pidada turuolude kõikumistele. Lisaks
pikendas ettevõte SEB Pangaga olemasoleva arvelduslaenulepingu tähtaega veel
aasta võrra. Grupp ei ole hetkel võõrvahendeid, pangalaene,
finantseerimistegevuseks kaasanud. 

PRFoods juhtkond on 2016. majandusaasta osas mõõdukalt optimistlik. Suurimaks
riskiks on lõhe hinnatõus, mis on tingitud maailmaturul valitsevast lõhe
defitsiidist. Lõhe hinnatõusu mõju kasumlikkusele jääb siiski piiratuks, kuna
kõik pakkujad on sunnitud hindu tõstma, sealhulgas ka jaesektor.  Küsimus on
selles, kui kaua lõhe defitsiit kestab. Tšiili kasvatuste probleemide tõttu
hinnatakse lõhe saadavust maailmaturul sel aastal 10–15% madalamaks. Teisest
küljest näeb PRFoods tekkinud turuolukorras soodsat võimalust, kuivõrd meie
teine põhiline tooraine ja oma kalakasvatustes toodetud kala, vikerforell, on
muutunud palju konkurentsivõimelisemaks. Vikerforell on odavam kui lõhe ning
lõhe kallinedes ostavad tarbijad rohkem odavamaid lõhelisi, sealhulgas
vikerforelli. 

AS PRFOODS AUDITEERIMATA MAJANDUSTULEMUSED, 1. KVARTAL 2016 VÕRRELDES 2015.
AASTA 1. KVARTALIGA 

  -- Auditeerimata konsolideeritud käive 10,2 miljonit eurot, kahanemine -0,06
     miljonit eurot ehk -0,6%.
  -- Brutomarginaal 9,5%, halvenemine -2,6 protsendipunkti.
  -- Bioloogiliste varade ümberhindluse negatiivne mõju -0,4 miljonit eurot
     (2015 aasta 1. kvartal negatiivne mõju -1,0 miljonit eurot).
  -- EBITDA äritegevusest 0,2 miljonit eurot, kahanemine -0,2 miljonit euro
     võrra ehk -47,6%.
  -- EBITDA -0,2 miljonit eurot, paranemine 0,4 miljonit eurot ehk 63,2%.
  -- Ärikahjum -0,5 miljonit eurot, paranemine 0,4 miljonit eurot ehk 39,8%.  
  -- Puhaskahjum -0,5 miljonit eurot, paranemine 0,08 miljonit eurot ehk 13,9%.

VÕTMENÄITAJAD                                                   
----------------------------------------------------------------
Kasumiaruanne, milj EUR         1kv 2016    1kv 2015    12k 2015
----------------------------------------------------------------
Müügitulu                           10,2        10,3        50,3
----------------------------------------------------------------
Brutokasum                           1,0         1,3         6,8
----------------------------------------------------------------
EBITDA äritegevusest                 0,2         0,4         2,9
----------------------------------------------------------------
EBITDA                              -0,2        -0,6         2,0
----------------------------------------------------------------
EBIT                                -0,5        -0,9         0,9
----------------------------------------------------------------
EBT                                 -0,6        -0,8         1,1
----------------------------------------------------------------
Puhaskasum (-kahjum)                -0,5        -0,5         1,2
----------------------------------------------------------------
Brutorentaablus                     9,5%       12,2%       13,5%
----------------------------------------------------------------
Äritegevuse EBITDA marginaal        2,1%        4,1%        5,8%
----------------------------------------------------------------
EBITDA marginaal                   -2,2%       -5,9%        4,0%
----------------------------------------------------------------
EBIT marginaal                     -5,2%       -8,6%        1,7%
----------------------------------------------------------------
EBT marginaal                      -5,5%       -7,4%        2,1%
----------------------------------------------------------------
Puhasrentaablus                    -4,5%       -5,2%        2,3%
----------------------------------------------------------------
Tegevuskulude suhtarv              10,5%       11,3%       10,8%
----------------------------------------------------------------
Bilanss, milj EUR             31.03.2016  31.03.2015  31.12.2015
----------------------------------------------------------------
Netovõlgnevus                       -3,1        -3,3        -0,6
----------------------------------------------------------------
Omakapital                          22,7        33,1        23,2
----------------------------------------------------------------
Käibekapital                        11,0        21,6        11,4
----------------------------------------------------------------
Varad                               28,6        39,5        29,5
----------------------------------------------------------------
Likviidsuskordaja                    3,7         5,5         3,7
----------------------------------------------------------------
Omakapitali suhtarv                79,4%       83,9%       78,8%
----------------------------------------------------------------
Finantsvõimendus                  -15,7%      -11,0%       -2,5%
----------------------------------------------------------------
Netovõlg/EBITDA                     -1,1       -11,2        -0,2
----------------------------------------------------------------
Omakapitali tootlus                 4,5%       -3,2%        4,1%
----------------------------------------------------------------
Varade tootlus                      3,7%       -2,1%        3,4%
----------------------------------------------------------------



KONSOLIDEERITUD FINANTSSEISUNDI ARUANNE

EUR '000                            31.03.2016  31.03.2015  31.12.2015
----------------------------------------------------------------------
VARAD                                                                 
----------------------------------------------------------------------
Raha ja ekvivalendid                     4 378       4 001       1 921
----------------------------------------------------------------------
Nõuded ja ettemaksed                     2 463      11 393       3 653
----------------------------------------------------------------------
Varud                                    5 754       7 387       5 616
----------------------------------------------------------------------
Bioloogilised varad                      2 451       3 579       4 421
----------------------------------------------------------------------
Käibevara kokku                         15 046      26 360      15 611
----------------------------------------------------------------------
                                                                      
----------------------------------------------------------------------
Edasilükkunud tulumaksuvara                138         103         138
----------------------------------------------------------------------
Pikaajalised finantsinvesteeringud         161         161         161
----------------------------------------------------------------------
Materiaalne põhivara                     7 178       6 672       7 427
----------------------------------------------------------------------
Immateriaalne vara                       6 109       6 194       6 128
----------------------------------------------------------------------
Põhivara kokku                          13 586      13 130      13 854
----------------------------------------------------------------------
VARAD KOKKU                             28 632      39 490      29 465
----------------------------------------------------------------------
                                                                      
----------------------------------------------------------------------
KOHUSTUSED JA OMAKAPITAL                                              
----------------------------------------------------------------------
Võlakohustused                             287         196         286
----------------------------------------------------------------------
Võlad ja ettemaksed                      3 617       4 412       3 760
----------------------------------------------------------------------
Sihtfinantseerimine                        164         184         177
----------------------------------------------------------------------
Lühiajalised kohustused kokku            4 068       4 792       4 223
----------------------------------------------------------------------
                                                                      
----------------------------------------------------------------------
Võlakohustused                           1 002         509       1 063
----------------------------------------------------------------------
Edasilükkunud tulumaksukohustus            152         229         252
----------------------------------------------------------------------
Sihtfinantseerimine                        677         827         706
----------------------------------------------------------------------
Pikaajalised kohustused kokku            1 831       1 565       2 021
----------------------------------------------------------------------
KOHUSTUSED KOKKU                         5 899       6 357       6 244
----------------------------------------------------------------------
                                                                      
----------------------------------------------------------------------
Aktsiakapital                            7 737      19 342       7 737
----------------------------------------------------------------------
Ülekurss                                16 026      16 026      16 026
----------------------------------------------------------------------
Oma aktsiad                               -190        -134        -172
----------------------------------------------------------------------
Kohustuslik reservkapital                    6           6           6
----------------------------------------------------------------------
Realiseerimata kursivahed                  465         458         471
----------------------------------------------------------------------
Jaotamata kahjum                        -1 311      -2 565        -847
----------------------------------------------------------------------
OMAKAPITAL  KOKKU                       22 733      33 133      23 221
----------------------------------------------------------------------
OMAKAPITAL JA KOHUSTUSED KOKKU          28 632      39 490      29 465
----------------------------------------------------------------------



KONSOLIDEERITUD KOONDKASUMIARUANNE

EUR '000                                                    1kv     1kv      12k
                                                           2016    2015     2015
--------------------------------------------------------------------------------
Müügitulud                                               10 235  10 299   50 273
--------------------------------------------------------------------------------
Müüdud kaupade kulu                                      -9 258  -9 044  -43 509
--------------------------------------------------------------------------------
Brutokasum                                                  977   1 255    6 764
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Tegevuskulud                                             -1 078  -1 168   -5 411
--------------------------------------------------------------------------------
Turundus- ja müügikulud                                    -766    -838   -4 033
--------------------------------------------------------------------------------
Üldhalduskulud                                             -312    -330   -1 378
--------------------------------------------------------------------------------
Muud äritulud/-kulud                                         12      55      406
--------------------------------------------------------------------------------
Bioloogiliste varade ümberhindlus                          -444  -1 028     -888
--------------------------------------------------------------------------------
Ärikasum (-kahjum)                                         -533    -886      871
--------------------------------------------------------------------------------
Finantstulud                                                  0     148      303
--------------------------------------------------------------------------------
Finantskulud                                                -32     -29     -105
--------------------------------------------------------------------------------
Maksustamiseelne kasum (-kahjum)                           -565    -767    1 069
--------------------------------------------------------------------------------
Tulumaks                                                    101     228      110
--------------------------------------------------------------------------------
Aruandeperioodi puhaskasum (-kahjum)                       -464    -539    1 179
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Muu koondkasum (-kahjum), mis on hiljem võimalik ümber                          
 klassifitseerida kasumiaruandesse:                                             
--------------------------------------------------------------------------------
Valuutakursi vahed                                           -6      17       30
--------------------------------------------------------------------------------
Kokku koondkasum (-kahjum)                                 -470    -522    1 209
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Aruandeperioodi koondkasumi (-kahjumi) jaotus:                                  
--------------------------------------------------------------------------------
emaettevõtte aktsionäridele kuuluv osa                     -470    -522    1 209
--------------------------------------------------------------------------------
Aruandeperioodi koondkahjum kokku                          -470    -522    1 209
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Tava puhaskasum (-kahjum) aktsia kohta (EUR)              -0,01   -0,01     0,03
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Lahustatud puhaskasum (-kahjum) aktsia kohta (EUR)        -0,01   -0,01     0,03
--------------------------------------------------------------------------------

Indrek Kasela
AS PRFoods
Juhatuse liige
T: +372  6033 800
[email protected]
www.prfoods.ee

Content of announcement in English

Title

PRF: Consolidated Unaudited Interim Report of AS PRFoods for 1st quarter of 2016

Message

Tallinn, Estonia, 2016-05-20 08:00 CEST (GLOBE NEWSWIRE) --


OVERVIEW OF THE ECONOMIC ACTIVITIES

MANAGEMENT COMMENTARY

The financial results of Q1 2016 are satisfying.  In spite of the fact that the
Company lost several private labels and HoReCa products from its product
portfolio, we managed to keep quarter sales on the same level with the same
period on previous year. Price surge of salmon has not yet been transferred to
end products since correction of prices in retail market are with inertia,
therefore correction of end prices should take place in the second half of the
year. The Company’s profit before taxes and amortization (EBITDA) improved by
half at the same time compared to the same period in previous year. The Group
balance sheet is strong which helps us resist unsteady market situation.
Additionally, the Company extended the overdraft contract in SEB Bank by a
year. The Group has not included any foreign resources or bank loans in its
financing activities. 

The Group management is sparingly optimistic with the financial year of 2016.
The biggest risk is increase in salmon prices, which is a result of deficiency
in the international market. Increase in salmon prices remains limited, though,
while all of the offerors, including retail market, are forced to increase
prices. The main question is how long will the salmon deficiency continue. As a
result of problems in Chilean fish farms, the availability of salmon in the
world market is estimated to be 10-15 % less on current year. On the other
hand, PRFoods sees the current market situation as a beneficial possibility
while the second main product of the Group fish breeding, the rainbow trout,
has turned out to be more competitive. Rainbow trout is cheaper than salmon and
as the salmon grows more expensive the clients will buy cheaper alternatives,
including the rainbow trout. 

UNAUDITED FINANCIAL RESULTS OF AS PRFOODS, THE 1ST QUARTER OF 2016 COMPARED TO
THE 1ST QUARTER OF 2015 

  -- Unaudited consolidated revenue 10.2 million euros, decrease -0.06 million
     euros, i.e. -0.6%.
  -- Gross margin 9.5%, decrease -2.6 percentage points.
  -- Negative impact from revaluation of biological assets -0.4 million euros
     (1st quarter 2015: negative impact of -1.0 million euros).
  -- EBITDA from operations 0.2 million euros, decrease -0.2 million euros, i.e.
     -47.6%.
  -- EBITDA -0.2 million euros, improvement 0.4 million euros, i.e. 63.2%.
  -- The operating loss -0.5 million euros, improvement 0.4 million euros, i.e.
     39.8%.
  -- Net loss -0.5 million euros, improvement 0.08 million euros, i.e. 13.9%.

KEY RATIOS                                                    
--------------------------------------------------------------
Profit & Loss, EUR mln     Q1 2016     Q1 2015    12m 2015
--------------------------------------------------------------
Sales                             10.2        10.3        50.3
--------------------------------------------------------------
Gross profit                       1.0         1.3         6.8
--------------------------------------------------------------
EBITDA from operations             0.2         0.4         2.9
--------------------------------------------------------------
EBITDA                            -0.2        -0.6         2.0
--------------------------------------------------------------
EBIT                              -0.5        -0.9         0.9
--------------------------------------------------------------
EBT                               -0.6        -0.8         1.1
--------------------------------------------------------------
Net profit (-loss)                -0.5        -0.5         1.2
--------------------------------------------------------------
Gross margin                      9.5%       12.2%       13.5%
--------------------------------------------------------------
Operational EBITDA margin         2.1%        4.1%        5.8%
--------------------------------------------------------------
EBITDA margin                    -2.2%       -5.9%        4.0%
--------------------------------------------------------------
EBIT margin                      -5.2%       -8.6%        1.7%
--------------------------------------------------------------
EBT margin                       -5.5%       -7.4%        2.1%
--------------------------------------------------------------
Net margin                       -4.5%       -5.2%        2.3%
--------------------------------------------------------------
Operating expense ratio          10.5%       11.3%       10.8%
--------------------------------------------------------------
Balance Sheet, EUR mln      31.03.2016  31.03.2015  31.12.2015
--------------------------------------------------------------
Net debt                          -3.1        -3.3        -0.6
--------------------------------------------------------------
Equity                            22.7        33.1        23.2
--------------------------------------------------------------
Working capital                   11.0        21.6        11.4
--------------------------------------------------------------
Assets                            28.6        39.5        29.5
--------------------------------------------------------------
Liquidity ratio                    3.7         5.5         3.7
--------------------------------------------------------------
Equity ratio                     79.4%       83.9%       78.8%
--------------------------------------------------------------
Gearing ratio                   -15.7%      -11.0%       -2.5%
--------------------------------------------------------------
Net debt-to-EBITDA                -1.1       -11.2        -0.2
--------------------------------------------------------------
ROE                               4.5%       -3.2%        4.1%
--------------------------------------------------------------
ROA                               3.7%       -2.1%        3.4%
--------------------------------------------------------------



CONSOLIDATED STATEMENT OF FINANCIAL POSITION

EUR '000                         31.03.2016  31.03.2015  31.12.2015
-------------------------------------------------------------------
ASSETS                                                             
-------------------------------------------------------------------
Cash and cash equivalents             4,378       4,001       1,921
-------------------------------------------------------------------
Receivables and prepayments           2,463      11,393       3,653
-------------------------------------------------------------------
Inventories                           5,754       7,387       5,616
-------------------------------------------------------------------
Biological assets                     2,451       3,579       4,421
-------------------------------------------------------------------
Total current assets                 15,046      26,360      15,611
-------------------------------------------------------------------
                                                                   
-------------------------------------------------------------------
Deferred income tax                     138         103         138
-------------------------------------------------------------------
Long-term financial investments         161         161         161
-------------------------------------------------------------------
Tangible fixed assets                 7,178       6,672       7,427
-------------------------------------------------------------------
Intangible assets                     6,109       6,194       6,128
-------------------------------------------------------------------
Total non-current assets             13,586      13,130      13,854
-------------------------------------------------------------------
TOTAL ASSETS                         28,632      39,490      29,465
-------------------------------------------------------------------
                                                                   
-------------------------------------------------------------------
EQUITY AND LIABILITIES                                             
-------------------------------------------------------------------
Loans and borrowings                    287         196         286
-------------------------------------------------------------------
Payables                              3,617       4,412       3,760
-------------------------------------------------------------------
Government grants                       164         184         177
-------------------------------------------------------------------
Total current liabilities             4,068       4,792       4,223
-------------------------------------------------------------------
                                                                   
-------------------------------------------------------------------
Loans and borrowings                  1,002         509       1,063
-------------------------------------------------------------------
Deferred tax liabilities                152         229         252
-------------------------------------------------------------------
Government grants                       677         827         706
-------------------------------------------------------------------
Total non-current liabilities         1,831       1,565       2,021
-------------------------------------------------------------------
TOTAL LIABILITIES                     5,899       6,357       6,244
-------------------------------------------------------------------
                                                                   
-------------------------------------------------------------------
Share capital                         7,737      19,342       7,737
-------------------------------------------------------------------
Share premium                        16,026      16,026      16,026
-------------------------------------------------------------------
Treasury shares                        -190        -134        -172
-------------------------------------------------------------------
Statutory capital reserve                 6           6           6
-------------------------------------------------------------------
Currency translation reserve            465         458         471
-------------------------------------------------------------------
Retained loss                        -1,311      -2,565        -847
-------------------------------------------------------------------
TOTAL EQUITY                         22,733      33,133      23,221
-------------------------------------------------------------------
TOTAL EQUITY AND LIABILITIES         28,632      39,490      29,465
-------------------------------------------------------------------



CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

EUR '000                                                     Q1      Q1      12m
                                                           2016    2015     2015
--------------------------------------------------------------------------------
Sales                                                    10,235  10,299   50,273
--------------------------------------------------------------------------------
Cost of goods sold                                       -9,258  -9,044  -43,509
--------------------------------------------------------------------------------
Gross profit                                                977   1,255    6,764
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Operating expenses                                       -1,078  -1,168   -5,411
--------------------------------------------------------------------------------
Selling and distribution expenses                          -766    -838   -4,033
--------------------------------------------------------------------------------
Administrative expenses                                    -312    -330   -1,378
--------------------------------------------------------------------------------
Other income/expenses                                        12      55      406
--------------------------------------------------------------------------------
Fair value adjustment on biological assets                 -444  -1,028     -888
--------------------------------------------------------------------------------
Operating profit (-loss)                                   -533    -886      871
--------------------------------------------------------------------------------
Financial income                                              0     148      303
--------------------------------------------------------------------------------
Financial expenses                                          -32     -29     -105
--------------------------------------------------------------------------------
Profit (-loss) before tax                                  -565    -767    1,069
--------------------------------------------------------------------------------
Income tax                                                  101     228      110
--------------------------------------------------------------------------------
Net profit (-loss) for the period                          -464    -539    1,179
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Other comprehensive income (-expense) that might                                
 subsequently classified to profit or loss:                                     
--------------------------------------------------------------------------------
Foreign currency translation differences                     -6      17       30
--------------------------------------------------------------------------------
Total comprehensive income (-expense)                      -470    -522    1,209
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Total comprehensive income (-expense) attributable to:                          
--------------------------------------------------------------------------------
Owners of the Company                                      -470    -522    1,209
--------------------------------------------------------------------------------
Total comprehensive income (-expense) for the period       -470    -522    1,209
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Profit (-loss) per share (EUR)                            -0.01   -0.01     0.03
--------------------------------------------------------------------------------
                                                                                
--------------------------------------------------------------------------------
Diluted profit (-loss) per share (EUR)                    -0.01   -0.01     0.03
--------------------------------------------------------------------------------

Indrek Kasela
AS PRFoods
Member of the Management Board
Phone: +372 6033 800
[email protected]
www.prfoods.ee